Document is current

Article History

Accepted: 5 February 2024

First Online: 23 February 2024

Compliance with Ethical Standards

:

: Dr. Vickery reports grants from Genentech, grants from NIH-NIAID, grants from Abbott, grants and personal fees from Aimmune, grants from Alladapt, personal fees from AllerGenis, personal fees from Aravax, grants and personal fees from DBV, grants and personal fees from FARE, stock options from Moonlight Therapeutics, personal fees from Reacta Biosciences, grants and personal fees from Regeneron, and grants from Siolta, outside the submitted work. Dr. Nowak-Wegrzyn receives research support from Alladapt Immunotherapeutics, DBV Technologies, Siolta Therapeutics, and Regeneron; speaking fees from Nestle, Danone, and Thermo Fisher; consulting fees from Aquestive; and royalties from UpToDate; she serves as an associate editor for the Annals of Allergy, Asthma and Immunology, chair of the ABAI Board of Directors, director of the AAAAI Board, and the chair of the Medical Advisory Board of the International FPIES. Drs. Ezhuthachan and Beaudoin have no relevant financial or non-financial interests to disclose.

: This article does not contain any studies with human or animal subjects performed by any of the authors.